Over a ten year period, the number of generic medicines withdrawn from the market increased by 12%

Research from Teva Pharmaceuticals shows that Europe’s critical medicine cabinets – ones in hospitals, pharmacies and homes – are home to fewer generic medicines. These are the often-cheaper alternatives to brand name medicines, that make up 67%[1] of all medicines.

During the last ten years, the number of generic medicines withdrawn from the market increased by 12%, while on average 3% fewer generics products were launched. In other words, on 31 December 2012, there were 40,280 separate generic products and 10 years later, only 29,836 generics were left – a 26% decline.

Generic medicines are part of the critical list of medicines adopted by the EU in December 2023, and are designed to treat serious illnesses in adults and children such as infectious diseases, cancer and mental health. ...[ManufacturingChemist]